BamSEC and AlphaSense Join Forces
Learn More

Anixa Biosciences Inc.

NASDAQ: ANIX    
Share price (11/21/24): $3.06    
Market cap (11/21/24): $98.5 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 25 pages Redactions With Respect to Certain Portions Hereof Denoted With “***” Joint Development and Option Agreement Preamble
12/34/56
EX-10.10
from 10-K 1 page Material contract
12/34/56
EX-10.1
from S-3 42 pages Anixa Biosciences, Inc. Shares of Common Stock (Par Value $0.01 Per Share) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Redactions With Respect to Certain Portions Hereof Denoted With “***” Amendment No. 1 to Exclusive License Agreement Between the Cleveland Clinic Foundation and Anixa Biosciences, Inc
12/34/56
EX-10.8
from 10-K 16 pages Material contract
12/34/56
EX-10.2
from 10-Q 3 pages Redactions With Respect to Certain Portions Hereof Denoted With “***”
12/34/56
EX-10.1
from 10-Q 5 pages Assignment Agreement
12/34/56
EX-10.2
from 10-Q 19 pages Background Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Redactions With Respect to Certain Portions Hereof Denoted With “***” Amendment of License Agreement
12/34/56
EX-10.14
from 10-K 40 pages Redactions With Respect to Certain Portions Hereof Denoted With “***” Exclusive License Agreement Between the Cleveland Clinic Foundation and Anixa Biosciences, Inc. Dated as of October 20, 2020 Redactions With Respect to Certain Portions Hereof Denoted With “***” Exclusive License Agreement
12/34/56
EX-10.13
from 10-K 2 pages Amendment to Collaboration Agreement
12/34/56
EX-10.10
from 10-K 3 pages Redactions With Respect to Certain Portions Hereof Denoted With “***” Amendment 2 to the Collaboration Agreement Between Certainty Therapeutics, Inc. and H. Lee Moffitt Cancer Center and Research Institute, Inc
12/34/56
EX-10.1
from 10-Q 15 pages Redactions With Respect to Certain Portions Hereof Denoted With “***” Collaboration Agreement
12/34/56
EX-10.2
from 10-Q ~5 pages Amendment 1 to the Collaboration Agreement Between Certainty Therapeutics, Inc. and H. Lee Moffitt Cancer Center and Research Institute, Inc
12/34/56
EX-10.1
from 10-Q 40 pages Redactions With Respect to Certain Portions Hereof Denoted With “***” Exclusive License Agreement Between the Cleveland Clinic Foundation and Anixa Biosciences, Inc. Dated as of July 8, 2019 Redactions With Respect to Certain Portions Hereof Denoted With “***” Exclusive License Agreement
12/34/56
EX-10.1
from S-3 41 pages Anixa Biosciences, Inc. Common Stock (Par Value $0.01 Per Share) at Market Issuance Sales Agreement
12/34/56
EX-10.1
from 8-K 43 pages ITUS Corporation Common Stock
12/34/56
EX-10.15
from 10-K 23 pages Irs Employer Identification No. 11-2622630
12/34/56
EX-10.14
from 10-K 39 pages Irs Employer Identification No. 11-2622630
12/34/56
EX-10.1
from 8-K 49 pages ITUS Corporation Common Stock (Par Value $0.01 Per Share) at Market Issuance Sales Agreement
12/34/56